NASDAQ · Medical - Devices

CODX (CODX) Stock

$2.04 -2.86% NASDAQ: CODX Healthcare

Valuation

MetricValue
Price$2.04
Market Cap$2.28M
P/E Ratio-0.11
P/B Ratio0.20
P/S Ratio5.77
EPS (TTM)$0.00
52-Week High$46.50
52-Week Low$1.26
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-223.81%
ROA-188.00%
ROCE-147.62%
Gross Margin-3100.00%
Operating Margin-3100.00%
Net Margin-67.54%
Debt/Equity0.13
Current Ratio3.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$98.0M$34.0M$7.0M$4.0M$1.0M
Operating Profit$46.0M$-27.0M$-43.0M$-40.0M$-31.0M
Net Profit$37.0M$-14.0M$-35.0M$-38.0M$-47.0M
EPS$36.90$-13.57$-36.00$-37.20$-35.25
Op Margin47.1%-78.8%-626.9%-1023.8%-5025.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$160.0M$123.0M$95.0M$64.0M$25.0M
Total Liabilities$26.0M$9.0M$9.0M$10.0M$4.0M
Cash$89.0M$23.0M$15.0M$3.0M$12.0M
Borrowings$0$0$3.0M$2.0M$1.0M

Latest News

Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test MT Newswires · Jul 22, 2026 Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform PR Newswire · Jul 22, 2026 EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin Benzinga · Jul 22, 2026 Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer PR Newswire · Jul 16, 2026 Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand PR Newswire · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$41.0M$7.0M$-22.0M$-29.0M$-29.0M
Investing Cash Flow$3.0M$-60.0M$14.0M$16.0M$26.0M
Financing Cash Flow$0$-14.0M$-1.0M$0$0
Net Cash Flow$46.0M$-66.0M$-8.0M$-12.0M$9.0M
Free Cash Flow$40.0M$5.0M$-23.0M$-30.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-699.98%
Quick Ratio2.09
Interest Coverage—
Return 1Y-68.91%
Return 3Y-93.85%
Return 5Y-98.94%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADGM $0.38 +1.60% -0.56 $8.45M 0.00%
AEMD $0.57 +6.51% -0.02 $430885 0.00%
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
DWTX $1.81 +3.14% 1.42 $3.45M 0.00%
NVNO $11.15 +4.21% -0.31 $184008 0.00%

About CODX

CODX is led by CEO Dwight H. Egan, employs 132 people, headquartered in US, publicly traded since 2017.

CODX stock trades at $2.04 with a market capitalization of $2.28M. The stock is valued at a price-to-earnings (P/E) ratio of -0.11, price-to-book of 0.20, price-to-sales of 5.77. Over the past 52 weeks the stock has ranged between $1.26 and $46.50, and currently trades 95.6% below its 52-week high.

On profitability, CODX generates a return on equity (ROE) of -223.81%, return on capital employed of -147.62%, an operating margin of -3100.00%, a net profit margin of -67.54%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides